Innovative Biotechnological Production of Antioxidant Products
NCT ID: NCT05679310
Last Updated: 2023-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2022-02-10
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating a Natural Antioxidant Food Product on Oxidative Stress in Recreationally Active Participants
NCT04959006
The Impact of OliPhenolia® Supplementation on Exercise Induced Inflammation and Functional Movement in Humans.
NCT07008586
The Effect of Postbiotics Supplementation on Exercise-induced Oxidative Stress.
NCT06417671
The Impact of Dietary Intervention on Oxidative/antioxidant Markers and Gut Microbiota in Athletes
NCT06855979
ABG Oxidative Stress Study Protocol-1
NCT02213523
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The volunteers are instructed to maintain their normal dietary habits. The following measurements will be taken: A) Dietary assessment at the beginning of the study (week 0), B) Body composition analysis at the beginning (week 0) and the end of the study (week 8), C) biochemical and laboratory analysis of plasma samples at week 0, 8 and 12.
The volunteers will record their food intake for 3 days (including one day of the weekend) and will fulfil a food frequency questionnaire. Analysis of their data will be done by a certified nutritionist. Nutritional assessment will be performed using the Evexis dietary software. The Tanita Dual Frequency Body Composition Monitor "Innerscan" will be employed to measure weight, muscle mass, muscle quality score, heart rate, body fat (%), physique rating, visceral fat, metabolic age, basal metabolic rate, bone mass, body water (%) and body mass index (BMI) in the morning. Physical activity will be assessed by the Greek version of the short International Physical Activity Questionnaire (IPAQ-short).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supplement
The supplement capsules were given to 12 healthy subjects, aged 26-52, once a day for 8 weeks
Hydroxytyrosol/Essential oils
A dietary supplement containing 10 mg of hydroxytyrosol, synthesised using genetically modified Escherichia coli strains and equal amounts (8.33 μL) of essential oils from oregano vulgaris, sage officinalis and crithmum maritimum.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hydroxytyrosol/Essential oils
A dietary supplement containing 10 mg of hydroxytyrosol, synthesised using genetically modified Escherichia coli strains and equal amounts (8.33 μL) of essential oils from oregano vulgaris, sage officinalis and crithmum maritimum.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the absence of any chronic health conditions
* adequate understanding of the study
Exclusion Criteria
* intake of nutritional supplements over the past 60 days
* heavy smokers (≥25 cigarettes/day)
* high alcohol use (men \>14 drinks/week, women \>7 drinks/week)
25 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ioannina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patra Vezyraki
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patra Vezyraki, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Ioannina, School of Health Sciences, Department of Medicine, Laboratory of Physiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ioannina
Ioannina, Epirus, Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
82436
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.